Lupus (SLE): vizsgálatok itt: Brazília
23 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Belo Horizonte, Porto Alegre, Rio de Janeiro, Salvador, São Paulo
- Életkor
- 5 év to 80 év
- People
- 1072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - 3. fázisTaking peoplePhase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Where
- Barretos, Belo Horizonte, Curitiba, Niterói, Rio de Janeiro, Salvador, São Paulo, Vitória
- Életkor
- 12 év to 100 év
- People
- 550 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06133972 · EU 2023-505929-14-00 - 3. fázisTaking peoplePhase III Extension Study of Efficacy and Safety of Ianalumab With or Without Study Treatment Withdrawal in Participants With Lupus Nephritis (SIRIUS-LN Extension)
- Where
- Belo Horizonte, Recife, Salvador, Santo André, Vitória
- Életkor
- 18 év to 100 év
- People
- 348 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06711887 · EU 2024-515280-60-00 - 1. fázisTaking peopleTo Evaluate the Effects of Cevostamab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
- Where
- Porto Alegre, Ribeirão Preto, Sao Jose Rio Preto
- Életkor
- 18 év to 75 év
- People
- 46 worldwide
- Run by
- Genentech, Inc.
See details and how to joinNCT07629583 · EU 2025-522904-26-00 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Where
- Barretos, Belo Horizonte, Cuiabá, Fortaleza, Salvador
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07332481 · EU 2025-523871-44-00 - 3. fázisTaking peopleA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Where
- Brasília, Campinas, São Paulo
- Életkor
- 18 év to 75 év
- People
- 202 worldwide
- Run by
- EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT07355218 · EU 2025-524855-30-00 - 2. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or IV Lupus Nephritis and the Safety and PK of Obinutuzumab in Pediatric Participants
- Where
- Campinas, Petrópolis, Salvado, Salvador, São Paulo
- Életkor
- 5 év to 17 év
- People
- 40 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT05039619 · EU 2023-505825-15-00 - 3. fázisTaking peopleA Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- Where
- Goiânia, Juiz de Fora, Porto Alegre, Ribeirão Preto, Salvador, São José do Rio Preto, São Paulo, Vitória
- Életkor
- 18 év to 75 év
- People
- 600 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07438496 · EU 2025-523552-31-00 - No phaseTaking peopleA Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Where
- Porto Alegre, São Paulo
- Életkor
- 16 év and over
- People
- 223 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07175285 - 2. fázisTaking peopleObe-cel in Severe, Refractory Systemic Lupus Erythematosus (SLE) With Active Lupus Nephritis (LN)
- Where
- Salvador
- Életkor
- 12 év to 65 év
- People
- 35 worldwide
- Run by
- Autolus Limited
See details and how to joinNCT07053800 · EU 2024-519941-32-00 - 1/2. fázisNot yet taking people in BrazíliaCD19-Directed CAR-T Cell Therapy in Refractory Systemic Lupus Erythematosus
- Where
- Ribeirão Preto, São Paulo
- Életkor
- 18 év to 50 év
- People
- 16
- Run by
- University of Sao Paulo
See details and how to joinNCT07659704 - 1. fázisTaking peopleStudy Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Where
- Porto Alegre, Salvador, São Paulo
- Életkor
- 18 év to 65 év
- People
- 48 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07201558 · EU 2025-522273-10-00 - 2. fázisTaking peopleA Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Where
- Curitiba, Juiz de Fora, Porto Alegre, Salvador, São José do Rio Preto, São Paulo, Valinhos
- Életkor
- 18 év to 74 év
- People
- 405 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07409181 · EU 2025-523488-39-00 - 2. fázisTaking peopleA Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
- Where
- Brasília, Cuiab, Niterói, Porto Alegre, Ribeiro Preto, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 30 worldwide
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07598396 · EU 2024-519930-22-00 - 3. fázisCsak meghívásosA Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and it's Effects on Symptoms in Adults With Systemic Lupus Erythematosus (SLE)
- Where
- Belo Horizonte, Brasília, Curitiba, Fortaleza, Juiz de Fora, Porto Alegre, Salvador, Santo Ângelo, São Bernardo do Campo, Sao Jose Rio Preto, São Paulo, Valinhos, Vitória
- Életkor
- 18 év and over
- People
- 864 worldwide
- Run by
- Biogen
See details and how to joinNCT05352919 · EU 2023-505635-13-00 - 2. fázisTaking peopleA Phase 2 Study to Evaluate the Safety, PD, PK, and Clinical Activity of ADX-097 in Participants With IgAN, LN or C3G
- Where
- São Paulo
- Életkor
- 16 év and over
- People
- 30 worldwide
- Run by
- Akebia Therapeutics
See details and how to joinNCT06419205 - 3. fázisTaking peopleAn Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Where
- Belo Horizonte, Porto Alegre, Ribeirão Preto, São Paulo
- Életkor
- 5 év to 17 év
- People
- 100 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05835310 · EU 2022-502289-25-00 - 3. fázisCsak meghívásosLong-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus
- Where
- Porto Alegre, Salvador
- Életkor
- 18 év to 75 év
- People
- 680 worldwide
- Run by
- Viatris Innovation GmbH
See details and how to joinNCT06475742 · EU 2024-514354-67-00 - 4. fázisTaking peopleSafety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
- Where
- São Paulo
- Életkor
- 12 év to 59 év
- People
- 477
- Run by
- University of Sao Paulo General Hospital
See details and how to joinNCT07087912 - 1. fázisTaking peopleA Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases
- Where
- Porto Alegre, Salvador, São Paulo
- Életkor
- 18 év and over
- People
- 125 worldwide
- Run by
- Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
See details and how to joinNCT07115745 · EU 2024-517681-41-00 - 1. fázisTaking peopleA Study of GSK5926371 in Participants With B-cell Driven Autoimmune Rheumatic Diseases (ARD)
- Where
- Campinas, São Paulo
- Életkor
- 18 év to 70 év
- People
- 44 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT07371468 · EU 2025-522932-15-00 - 1. fázisTaking peopleA Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
- Where
- Juiz de Fora, Porto Alegre, Salvador
- Életkor
- 18 év to 65 év
- People
- 142 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06576271 · EU 2024-514186-18-00 - No phaseNot yet taking people in BrazíliaTherapeutic Drug Monitoring of Mycophenolate Mofetil in Lupus Nephritis
- Where
- São Luís
- Életkor
- 18 év and over
- People
- 100
- Run by
- Federal University of Maranhao
See details and how to joinNCT07493655